Bnp Paribas Asset Management Holding S.A. Ionis Pharmaceuticals Inc Transaction History
Bnp Paribas Asset Management Holding S.A.
- $40.3 Billion
- Q4 2024
A detailed history of Bnp Paribas Asset Management Holding S.A. transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Bnp Paribas Asset Management Holding S.A. holds 1,080,341 shares of IONS stock, worth $35.6 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
1,080,341
Previous 779,721
38.55%
Holding current value
$35.6 Million
Previous $31.2 Million
20.91%
% of portfolio
0.09%
Previous 0.08%
Shares
7 transactions
Others Institutions Holding IONS
# of Institutions
412Shares Held
140MCall Options Held
829KPut Options Held
789K-
Vanguard Group Inc Valley Forge, PA16.5MShares$542 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD14.2MShares$466 Million0.31% of portfolio
-
Capital World Investors Los Angeles, CA11.5MShares$377 Million0.06% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$340 Million0.01% of portfolio
-
Bellevue Group Ag Kuesnacht, V87.87MShares$259 Million5.48% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $4.67B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...